Search clinical trials for: F1: TROP2 ADC
Total 2879 results
-
Fudan UniversityRecruiting
-
Fudan UniversityActive, not recruiting
-
Sorrento Therapeutics, Inc.WithdrawnSolid Tumor, Adult | Refractory Cancer | Relapsed Solid Neoplasm
-
Neuronoff, IncOhio Pain ClinicCompletedChronic Pain | Lower Back Pain ChronicUnited States
-
The Immunobiological Technology Institute (Bio-Manguinhos)...Oswaldo Cruz InstituteNot yet recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Terminated
-
Jiangsu Province Centers for Disease Control and...Active, not recruiting
-
Luye Pharma Group Ltd.Enrolling by invitationParkinson's DiseaseAustralia
-
IDRIAmerican Leprosy MissionsCompleted
-
Marius PharmaceuticalsSyneos HealthCompletedHypogonadism, MaleUnited States
-
Chong Kun Dang PharmaceuticalSeoul National University Bundang HospitalCompletedHealthyKorea, Republic of
-
National Institute of Allergy and Infectious Diseases...Completed
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Bharat Biotech International LimitedGeorgia Institute for Clinical Research, LLCCompleted
-
Rovi Pharmaceuticals LaboratoriesRecruiting
-
GlaxoSmithKlineCompleted
-
Seoul National University HospitalNewGenPharm Inc.CompletedPancreatic CancerKorea, Republic of
-
National Institute of Allergy and Infectious Diseases...Recruiting
-
Bio-Thera SolutionsNot yet recruiting
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
Chong Kun Dang PharmaceuticalCompletedClinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersChronic Renal FailureKorea, Republic of
-
Henry Ford Health SystemRecruitingGlioma | Glioblastoma | Astrocytoma | Malignant Glioma of Brain | Brain Cancer | Brain Tumor | Glioblastoma Multiforme | GBM | Malignant AstrocytomaUnited States
-
Helios Albert-Schweitzer-Klinik NortheimCompletedColorectal Polyps | Colorectal AdenomasGermany, Poland
-
Chong Kun Dang PharmaceuticalUnknown
-
University of WashingtonRecruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Refractory Mantle Cell Lymphoma | Recurrent Follicular... and other conditionsUnited States
-
National Institute of Mental Health and Neuro Sciences...Completed
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Heinrich Elinzano, MDUniversity of Texas; Rhode Island Hospital; Progenics Pharmaceuticals, Inc.CompletedGlioblastoma Multiforme | Gliosarcoma | GBMUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...CompletedRefractory or Recurrent CD30+ Hematologic MalignanciesChina
-
RemeGen Co., Ltd.Completed
-
RemeGen Co., Ltd.Completed
-
Benjamin Movsas, M.D.WithdrawnNon-small Cell Lung Cancer Stage IUnited States
-
Henry Ford Health SystemCompleted
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Henry Ford Health SystemTerminatedPancreatic CancerUnited States
-
RemeGen Co., Ltd.Completed
-
CytokineticsCompletedChronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | EchocardiogramUnited States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
-
Shanxi Province Cancer HospitalCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Jiangsu Cancer Institute & HospitalNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaboratorsNot yet recruitingNeoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
-
RemeGen Co., Ltd.RecruitingMuscle Invasive Bladder CarcinomaChina
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Memorial Sloan Kettering Cancer CenterPfizerCompleted
-
Chinese PLA General HospitalRecruitingAdvanced Gastroesophageal AdenocarcinomaChina
-
Genentech, Inc.Completed
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina